Incorporating The Voices Of Parents And Children In Pediatric Clinical Trials
By Annick de Bruin and Shipra Patel, M.D.
A survey of families provides critical insights about their motivations and challenges.
Ensuring the health and well-being of children is essential in any setting, but pediatric clinical trials present an especially vulnerable environment in which children’s safety is paramount. Indeed, pediatric trials are far more complex and multifaceted than simply evaluating a therapy in the context of a child’s disease or illness. They are a family affair that must accommodate the diverse needs of parents, siblings, and often extended family members who care for children with chronic and acute illnesses.
01.25.21 Research Report Shows Phase II/III Spending Will Increase
Continuing our Cell & Gene Series,
Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode.
Featured Editorial
Research firm Industry Standard Research recently published its
Phase II/III Study Trends and Market Outlook report. The goal of this report is to provide readers with a high-level view of the Phase 2 and 3 clinical development space to illustrate current market dynamics and inform strategic planning.